Avantax Planning Partners, Inc. Amicus Therapeutics, Inc. Transaction History

Avantax Planning Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$8.38 - $13.44 $2,949 - $4,730	-352 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$11.6 - $16.54 $4,083 - $5,822	352 New	352 $4,000
Q2 2018 Aug 13, 2018	SELL	$13.13 - $17.09 $3,348 - $4,357	-255 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$13.76 - $17.12 $3,508 - $4,365	255 New	255 $4,000

311

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Avantax Planning Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Avantax Planning Partners, Inc. with notifications on news.